Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has signed a research collaboration and option agreement with Columbia University to explore precision medicine approaches for vaccines and therapeutics against Covid-19.
The partners will study the immune responses to Covid-19 in healthy volunteers who recovered from the disease or were asymptomatic.
The focus will be on T-cell and antibody responses at the cellular level. The research should help in better understanding of the detailed immune responses to the disease.